Luda Kopeikina - Profile and Investment Details

Investor Profile

Luda Kopeikina is a Corporate Venture Capital based in Cambridge, United States with a diverse investment portfolio that includes companies such as IntegraGen, ChromaDex, EyePromise, Morphotek, Frontier Nutrition, Isobionics, Novomer, Blue Prairie, Hyalex Orthopaedics, Ganeden Biotech, ORYXE Energy International, Inkbit, Leading Edge Equipment Technologies, Food Quality Sensor International, Sciona, NOMADD, Adaptive3D, Panaceutics Nutrition, QD Solar Inc., Viocare, Meatable, Upfront Chromatography, Harland Medical Systems, Provexis, CellMade, Raycatch, Tespo, Optiva, Micromuscle, Additive Manufacturing Technologies, Novum Medical, Deep Branch Biotechnology, Chromatic 3D Materials, Miach Orthopaedics, Segetis, ATRO Medical, Arecor, Chinova Bioworks, WattGlass, Verdezyne, ZeaVision, Essential Medical, NutriLeads, Phynova Group, Natreon, NovoPolymers, Regentis Biomaterials, Voxel8, Xolve, Interface Biologics, Inc.. Over time, Luda Kopeikina has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Luda Kopeikina is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Wellness, Women Founded, Consumer Goods, Gyms, 3D Printing, Food Processing, Organic Food, 3D Technology, Medical Device, Software, Manufacturing, Biotechnology, Hispanic / Latinx Founded, Nutrition, Food and Beverage, Personalization, Industrial, Innovation Management, Nanotechnology, Machinery Manufacturing, Fitness, Machine Learning, Packaging Services, Packaged Goods may find it worthwhile to explore potential connections with Luda Kopeikina, as their portfolio suggests a familiarity and interest in this area.

Understanding Luda Kopeikina’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.